F.A.Q.

Frequently Asked Questions.​

Have additional questions? Drop us a line via form below.

How is amyloidosis diagnosed?

Diagnosis typically involves a combination of clinical evaluation, imaging studies, and biopsy to identify amyloid deposits. Techniques like Congo red staining and electron microscopy can provide clear evidence of amyloid presence.

  1. Cardiac: Heart failure, arrhythmias, and conduction disorders.
  2. Renal: Proteinuria and kidney failure.
  3. Hepatic: Liver dysfunction and elevated liver enzymes.
  4. Neurologic: Peripheral neuropathy and autonomic dysfunction.
  5. Gastrointestinal: Malabsorption and gastrointestinal bleeding.

Absolutely! Advances in research and treatment options are continuously improving outcomes. Many patients respond well to therapies, and ongoing clinical trials are exploring new avenues for effective management.

PET scans are one of the methods, but other imaging and diagnostic tools are also available. The frequency of scans may vary based on individual cases and medical advice.

The timing varies, often based on treatment response.

Yes, proteinuria often indicates kidney involvement, a common manifestation in amyloidosis.

Some patients may experience stabilisation or improvement in kidney function, depending on treatment and disease progression. Early detection and intervention are crucial.

Yes, amyloidosis can lead to increased creatinine levels if the kidneys are involved, indicating decreased kidney function.

Cardiac involvement refers to the deposition of amyloid in the heart tissue, which can impair heart function and lead to symptoms such as heart failure and arrhythmias.

Yes, shortness of breath is often a symptom due to the reduced ability of the heart to pump blood effectively.

Tests like echocardiograms, cardiac MRI, and certain biomarkers (such as NT-proBNP and troponin) help assess cardiac involvement.

Yes, autologous stem cell transplantation is an option for certain types of amyloidosis, such as AL amyloidosis, but not all patients are suitable candidates.

Chemotherapy side effects can vary but may include fatigue, nausea, hair loss, and increased susceptibility to infections.

Relapse refers to the reappearance of amyloid-related symptoms or organ dysfunction after an initial response to treatment

Yes, supportive care such as physical therapy, dietary adjustments, and symptom management can greatly improve the quality of life.

Follow-up frequency depends on the patient’s condition and treatment plan, typically ranging from every few months to yearly evaluations.

Yes, regular tests are critical to monitor the impact of amyloidosis on organs and to adjust treatments accordingly.

Imaging methods such as MRI, PET scans, and echocardiograms are useful in tracking disease progression, depending on which organs are affected.

Light to moderate exercise may be recommended based on individual tolerance and organ involvement. Always consult a healthcare provider before starting any exercise program.

Chronic stress can impact overall health and potentially exacerbate symptoms, so stress management is important in amyloidosis care.

Diagnosis typically involves a combination of clinical evaluation, imaging studies, and biopsy to identify amyloid deposits. Techniques like Congo red staining and electron microscopy can provide clear evidence of amyloid presence.

  1. Cardiac: Heart failure, arrhythmias, and conduction disorders.
  2. Renal: Proteinuria and kidney failure.
  3. Hepatic: Liver dysfunction and elevated liver enzymes.
  4. Neurologic: Peripheral neuropathy and autonomic dysfunction.
  5. Gastrointestinal: Malabsorption and gastrointestinal bleeding.

Absolutely! Advances in research and treatment options are continuously improving outcomes. Many patients respond well to therapies, and ongoing clinical trials are exploring new avenues for effective management.

PET scans are one of the methods, but other imaging and diagnostic tools are also available. The frequency of scans may vary based on individual cases and medical advice.

The timing varies, often based on treatment response.

Yes, proteinuria often indicates kidney involvement, a common manifestation in amyloidosis.

Some patients may experience stabilisation or improvement in kidney function, depending on treatment and disease progression. Early detection and intervention are crucial.

Yes, amyloidosis can lead to increased creatinine levels if the kidneys are involved, indicating decreased kidney function.

Cardiac involvement refers to the deposition of amyloid in the heart tissue, which can impair heart function and lead to symptoms such as heart failure and arrhythmias.

Yes, shortness of breath is often a symptom due to the reduced ability of the heart to pump blood effectively.

Tests like echocardiograms, cardiac MRI, and certain biomarkers (such as NT-proBNP and troponin) help assess cardiac involvement.

Yes, autologous stem cell transplantation is an option for certain types of amyloidosis, such as AL amyloidosis, but not all patients are suitable candidates.

Chemotherapy side effects can vary but may include fatigue, nausea, hair loss, and increased susceptibility to infections.

Relapse refers to the reappearance of amyloid-related symptoms or organ dysfunction after an initial response to treatment

Yes, supportive care such as physical therapy, dietary adjustments, and symptom management can greatly improve the quality of life.

Follow-up frequency depends on the patient’s condition and treatment plan, typically ranging from every few months to yearly evaluations.

Yes, regular tests are critical to monitor the impact of amyloidosis on organs and to adjust treatments accordingly.

Imaging methods such as MRI, PET scans, and echocardiograms are useful in tracking disease progression, depending on which organs are affected.

Light to moderate exercise may be recommended based on individual tolerance and organ involvement. Always consult a healthcare provider before starting any exercise program.

Chronic stress can impact overall health and potentially exacerbate symptoms, so stress management is important in amyloidosis care.

Still have questions?

Join the Fight Against Amyloidosis – Together, We Are Stronger!

Be part of a supportive community, learn from experts, and make an impact.

Have more

Questions?

We’re always here to help.

Drop us a line and we’ll answer very soon.

Scroll to Top